Carvedilol (Crv) inhibe la vía autofágica de Trypanosoma cruzi afectando la replicación y supervivencia parasitaria.

RIVERO CV; ROMANO PS

Mendoza

Simposio; II International Symposium of Traslational Medicine.; 2019

Facultad de Ciencias Medicas. UNCUYO.

Background:Chagas disease is caused by the protozoan T.cruzi. Pathogenesis of Chagas heart disease (CHD) involves low-grade incessant systemic infection and triggered autoimmune reaction. Cruzipain (CZP) is a key virulence factor of T. cruzi. Autophagy is an intracellular (IC) pathway that affects survival and/or virulence of parasites.A recent study showed that Crv was effective in reducing oxidative damage in CHD.Methods:The effect of Crv on T. cruzi epimastigotes was evaluated on Y-GFP strains maintained in BHT medium. Crv10 M was added and compared with control. Replication was counted in Neubauer chamber (Fig 1).To observe effect of Crv on amastigotes, rat cardiomyoblast H9C2 cell lines were infected with T. cruzi trypomastigotes Y-GFP for 24 h, then treated with Crv10 M for 96 h. IC replication was evaluated counting amastigotes per cell by microscopy.Parasite autophagy was studied staining epimastigotes with (monodansylcadaverine) MDC (Fig 3) and TcAtg8 (T. cruzi specific protein of autophagosomes). Acidic and degradative compartments of T. cruzi were studied by Lysotracker and DQ BSA staining.Results:Crv at doses of 10 M has significant inhibitory effect on proliferation of epimastigotes (p